Lmr Partners LLP Vyne Therapeutics Inc. Call Options Transaction History
Lmr Partners LLP
- $10.5 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VYNE
# of Institutions
4Shares Held
52.2KCall Options Held
0Put Options Held
0-
Staley Capital Advisers Inc51.5KShares$18,5290.0% of portfolio
-
Fortitude Family Office, LLC Scottsdale, AZ680Shares$2440.0% of portfolio
-
Farther Finance Advisors, LLC San Francisco, CA16Shares$50.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$0100.0% of portfolio
About VYNE Therapeutics Inc.
- Ticker VYNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,005,600
- Market Cap $20.9M
- Description
- VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...